Risk of Anaphylaxis With Intravenous Iron Products

Affiliations

¹ Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
² ACUMEN LLC, Burlingame, California.

Comment

Cunlin Wang et al. JAMA. 2016 May.

. 2016 May;315(20):2232-3.

doi: 10.1001/jama.2016.0965.

¹ Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
² ACUMEN LLC, Burlingame, California.

No abstract available

Comment on

Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
Wang C, Graham DJ, Kane RC, Xie D, Wernecke M, Levenson M, MaCurdy TE, Houstoun M, Ryan Q, Wong S, Mott K, Sheu TC, Limb S, Worrall C, Kelman JA, Reichman ME. Wang C, et al. JAMA. 2015 Nov 17;314(19):2062-8. doi: 10.1001/jama.2015.15572. JAMA. 2015. PMID: 26575062
Risk of Anaphylaxis With Intravenous Iron Products.
DeLoughery TG. DeLoughery TG. JAMA. 2016 May 24-31;315(20):2232. doi: 10.1001/jama.2016.0962. JAMA. 2016. PMID: 27218635 No abstract available.